Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$148,412,479
-$475,008 QoQ
Shares Held
6,163,309
+16.2% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#80
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $3,276,463,441 across 12 Drug Manufacturers - General names. PFE ranks #7 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
682,818 | $818,992,461 | |
| 2 | JNJ |
Johnson & Johnson
|
2,447,058 | $621,479,319 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,309,756 | $553,803,646 | |
| 4 | ABBV |
AbbVie Inc.
|
2,052,285 | $516,436,996 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
3,222,190 | $185,662,586 | |
| 6 | AMGN |
Amgen Inc
|
489,514 | $177,262,808 | |
| 7 | PFE |
Pfizer Inc
This page
|
6,163,309 | $148,412,479 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,003,515 | $126,784,084 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $148,412,479 | 6,163,309 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $148,887,487 | 5,302,261 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $129,615,778 | 5,205,453 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $149,574,070 | 5,870,254 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $127,808,089 | 5,272,611 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $125,031,360 | 4,934,150 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $99,155,529 | 3,737,487 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $129,617,339 | 4,478,830 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $118,142,919 | 4,222,406 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $122,809,344 | 4,425,562 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $128,671,117 | 4,469,299 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $71,236,819 | 2,147,628 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $79,350,172 | 2,163,309 | Shares | Defined | 2024-06-20 | |
| 2023-03-31 | $87,864,593 | 2,153,544 | Shares | Defined | 2024-06-20 | |
| 2022-12-31 | $101,754,644 | 1,985,844 | Shares | Defined | 2024-06-20 | |
| 2022-09-30 | $81,665,872 | 1,866,222 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $86,264,701 | 1,645,331 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $88,203,653 | 1,703,760 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $166,175,378 | 2,814,147 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $121,844,748 | 2,832,940 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $113,572,065 | 2,900,206 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $112,730,151 | 3,111,514 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $96,504,702 | 2,621,698 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $98,363,055 | 2,680,195 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $97,921,395 | 2,994,535 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $94,692,457 | 2,901,121 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||